{"SLR NAME":"Acute cardiac injury in patients suffering from COVID-19 infection; a systematic review and meta-analysis","References":[{"title1":"Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]}]},{"title1":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"Ahmadi KS, Vahabizad F, Banihashemi G, Sahraian MA,  Gheini MR, Eslami M, Marhamati H, Mirhadi MS (2020) Ischemic stroke in patients with COVID-19 disease: a report of 10 cases from Iran Cerebrovasc Dis 1-6 10.1159/000513279"},{"title3":"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19"},{"title3":"COVID-19 infection recurrence presenting with meningoencephalitis"},{"title3":"Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN (2020) COVID-19 associated central nervous system vasculopathy Can J Neurol Sci 1-6 10.1017/cjn.2020.1092020.1092020.1092020.109"},{"title3":"Focal cerebral arteriopathy in a COVID-19 pediatric patient"},{"title3":"An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19"},{"title3":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2"},{"title3":"COVID-19, SARS and MERS: a neurological perspective"},{"title3":"Frontier therapeutics and vaccine strategies for sars-cov-2 (COVID-19): a review"},{"title3":"A review of Coronavirus Disease-2019 (COVID-19)"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses Brain Behav Immun 18-22 10.1016/j.bbi.2020.03.0312020.03.0312020.03.0312020.03.031"},{"title3":"Encephalitis as a clinical manifestation of COVID-19"},{"title3":"Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review"}]},{"title2":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","References":[{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Children with respiratory disease associated with metapneumovirus in Hong Kong"},{"title3":"Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay"},{"title3":"Characterization of human metapneumoviruses isolated from patients in North America"},{"title3":"Chan PKS, Tam JS, Lam CW, etal. Detection of human metapneumovirus from patients with severe acute respiratory syndrome: a methodological evaluation. Emerg Infect Dis (in press)."},{"title3":"Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene"},{"title3":"Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction"},{"title3":"Rapid and standardised detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR"},{"title3":"A newly discovered human metapneumovirus isolated from young children with respiratory tract disease"},{"title3":"Experimental infection of adult axenic rats with Parker's rat coronavirus"},{"title3":"Pathogenicity of experimental infection with 'pneumotropic' porcine coronavirus"},{"title3":"Pathogenicity of porcine respiratory coronavirus isolated in Quebec"},{"title3":"Measles virus and immunomodulation: molecular bases and perspectives"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV)","References":[]},{"title2":"Novel coronavirus - China","References":[]},{"title2":"Novel coronavirus - Thailand (ex-China)","References":[{"title3":"Life experiences and support perceived by nurses in hospital haemodialysis units during the COVID-19 pandemic in Spain"},{"title3":"Connecting with generation Z: Approaches in nursing education"},{"title3":"Qualitative descriptive methods in health science research"},{"title3":"The characteristic of generation Z"},{"title3":"Nurses at the front line of COVID-19: Roles, responsibilities, risks, and rights"},{"title3":"Implications for COVID-19: A systematic review of nurses' experiences of working in acute care hospital settings during a respiratory pandemic"},{"title3":"Exploring nurses' experiences of psychological distress during care of patients with COVID-19: A qualitative study"},{"title3":"Novice nurse's transitioning to emergency nurse during COVID-19 pandemic: A qualitative study"},{"title3":"Generation Z students: Will they change our nursing classrooms?"},{"title3":"Novice nurses' experiences of unpreparedness at the beginning of the work"},{"title3":"Frontline nurses' burnout, anxiety, depression, and fear statuses and their associated factors during the COVID-19 outbreak in Wuhan, China: A large-scale cross-sectional study"},{"title3":"New graduate nurses' experiences in a clinical specialty: A follow up study of newcomer perceptions of transitional support"},{"title3":"Experiences and psychosocial problems of nurses caring for patients diagnosed with COVID-19 in Turkey: A qualitative study"},{"title3":"Final clinical practicum, transition experience and turnover intentions among newly graduated nurses: A cross sectional study"},{"title3":"The impact of human resource development on organizational effectiveness: An empirical study"},{"title3":"The lived experience of nurses caring for patients with COVID-19 in Iran: A phenomenological study"},{"title3":"The experiences of health-care providers during the COVID-19 crisis in China: A qualitative study"},{"title3":"Experiences of nurses during the COVID-19 pandemic: A mixed-methods study"},{"title3":"Rapid deployment of critical care nurse education during the COVID-19 pandemic"},{"title3":"Effective orientation programs for new graduate nurses: A systematic review"},{"title3":"Exploring nursing managers' perceptions of nursing workforce management during the outbreak of COVID-19: A content analysis study"},{"title3":"Coronavirus infectious disease-2019 (COVID-19): A case report, the first patient in Thailand and outside China"},{"title3":"Nursing experiences of COVID-19 outbreak in Iran: A qualitative study"},{"title3":"Experiences of geriatric nurses in nursing home settings across four countries in the face of the COVID-19 pandemic"},{"title3":"Deciding about the use of a personal safety alerting device:The need for a legitimation process: A qualitative study"},{"title3":"Nurses on the frontline against the COVID-19 pandemic: An integrative review"},{"title3":"The impact of human resource development (HRD) practices on organizational effectiveness: A review"},{"title3":"Holistic care for patients with severe coronavirus disease 2019: An expert consensus"},{"title3":"The experience of transition from nursing students to newly graduated registered nurses in Singapore"},{"title3":"Nurses' psychological changes and coping strategies during home isolation for the 2019 novel coronavirus in China: A qualitative study"}]},{"title2":"Novel coronavirus - Japan (ex-China)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"WHO. WHO coronavirus (COVID-19) (2022) dashboard https://covid19.who.int/"},{"title3":"Early dynamics of transmission and control of COVID-19: A mathematical modelling study"},{"title3":"A review on COVID-19 forecasting models"},{"title3":"Predictive models of COVID-19 in India: A rapid review"},{"title3":"Forecasting the spread of COVID-19 under different reopening strategies"},{"title3":"A modified age-structured SIR model for COVID-19 type viruses"},{"title3":"Inefficiency of SIR models in forecasting COVID-19 epidemic: A case study of Isfahan"},{"title3":"Baek, J. et al. (2020) The limits to learning an sir process granular for COVID-19. Preprint at arXiv:2006.06373v1"},{"title3":"Quantifying the time-lag effects of human mobility on the COVID-19 transmission: A multi-city study in China"},{"title3":"The effect of population mobility on COVID-19 incidence in 314 Latin American cities: A longitudinal ecological study with mobile phone location data"},{"title3":"Changes in social environment due to the state of emergency and go to campaign during the COVID-19 pandemic in Japan: An ecological study"},{"title3":"The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan"},{"title3":"Mobility network models of COVID-19 explain inequities and inform reopening"},{"title3":"Commentary on Ferguson, et al., impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand"},{"title3":"Member of WIN and Gallup International Association. (2022) NR YouGov information https://www.nrc.co.jp/nryg/211227.html"},{"title3":"The &lt;Three Cs&gt; of Japan's pandemic response as an ideograph"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Agent-based modeling for super-spreading events: A case study of MERS-CoV transmission dynamics in the Republic of Korea"},{"title3":"Mobility change and COVID-19 in Japan: Mobile data analysis of locations of infection"},{"title3":"Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic"},{"title3":"Reduction in mobility and COVID-19 transmission"},{"title3":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak"},{"title3":"Shorter incubation period among unvaccinated delta variant coronavirus disease 2019 patients in Japan"},{"title3":"Shorter incubation period among COVID-19 cases with the BA.1 Omicron variant"},{"title3":"Association between mobility patterns and COVID-19 transmission in the USA: A mathematical modelling study"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in china"},{"title3":"Ogiwara, K. (2021) Coronavirus disease (COVID-19) situation report in Japan https://toyokeizai.net/sp/visual/tko/covid19/en.html"},{"title3":"Tokyo Metropolitan Government. (2020) Number of Ovid-19 positive cases by date of onset https://stopcovid19.metro.tokyo.lg.jp/cards/positive-number-by-developed-date/"},{"title3":"Number of subscribers by carriers. (2021) Webpage in Japanese. Telecommunications Carriers Association. https://www.tca.or.jp/database/"},{"title3":"A contribution to the mathematical theory of epidemics"},{"title3":"The approximately universal shapes of epidemic curves in the Susceptible-Exposed-Infectious-Recovered (SEIR) model"},{"title3":"Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions"},{"title3":"A cluster analysis method for grouping means in the analysis of variance"},{"title3":"Geometric interpretation of gene coexpression network analysis"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks"},{"title3":"Toyo Keizai Online The novel coronavirus diseaseDisease (COVID-19) Situation Report in Japan. https://toyokeizai.net/sp/visual/tko/covid19/en.html."}]},{"title2":"Novel coronavirus - Republic of Korea (ex-China)","References":[{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Early Epidemiological and Clinical Characteristics of 28 cases of Coronavirus Disease in South Korea"},{"title3":"Coronavirus Disease-19: Summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea"},{"title3":"Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards"},{"title3":"Environmental Contamination and Viral Shedding in MERS Patients during MERS-CoV Outbreak in South Korea"},{"title3":"Airflow as a possible transmission route of Middle East respiratory syndrome at an initial outbreak hospital in Korea"},{"title3":"Airflow analysis of Pyeongtaek St. Mary's hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"title3":"Identification of coronavirus isolated from a patient in Korea with COVID-19"},{"title3":"A lesson from temporary closing of a single university-affiliated hospital owing to in-hospital transmission of coronavirus disease 2019"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"}]},{"title2":"First travel-related case of 2019 novel coronavirus detected in United States","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia","References":[]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"CDC definitions for nosocomial infections, 1988","References":[]},{"title2":"Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus","References":[{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series."},{"title3":"The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019."},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection."},{"title3":"Clinicopathologic study of thirty-three fatal cases of Asian influenza."},{"title3":"Observations on the A2 England influenza epidemic: A clinicopathological study."},{"title3":"Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection."},{"title3":"2009 pandemic H1N1-associated myocarditis in a previously healthy adult."},{"title3":"Influenza myocarditis and myositis: Case presentation and review of the literature."},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care."},{"title3":"Cardiac complications of influenza infection in 3 adults."},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection."},{"title3":"Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care."},{"title3":"Influenza, autoimmunity and atherogenesis."},{"title3":"Cardiovascular manifestations associated with influenza virus infection."},{"title3":"The cardiovascular manifestations of influenza: a systematic review."},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection."},{"title3":"Epidemiology of human infections with avian influenza A(H7N9) virus in China."},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review."},{"title3":"Fourth Universal Definition of Myocardial Infarction (2018)."},{"title3":"The prevalence and findings of subclinical influenza-associated cardiac abnormalities among Japanese patients."},{"title3":"Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension."},{"title3":"Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography."},{"title3":"2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"KDIGO clinical practice guidelines for acute kidney injury."},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis."},{"title3":"Adjuvant corticosteroid treatment in adults with influenza a (H7N9) viral pneumonia."},{"title3":"A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support."},{"title3":"Acute cardiac injury events &lt;=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial."},{"title3":"Transient cardiac injury during H7N9 infection."},{"title3":"Relation of concomitant heart failure to outcomes in patients hospitalized with influenza."},{"title3":"Extreme influenza epidemics and out-of-hospital cardiac arrest."},{"title3":"Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study."},{"title3":"The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis."},{"title3":"Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations."},{"title3":"Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection."},{"title3":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection."},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09."},{"title3":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG."},{"title3":"The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: Results of two international observational cohort studies."},{"title3":"Myocardial dysfunction in severe sepsis and septic shock: More questions than answers?"},{"title3":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction."},{"title3":"Acute infection and myocardial infarction."},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection."},{"title3":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?"}]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro"},{"title3":"Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4alpha"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"The small envelope protein E is not essential for murine coronavirus replication"},{"title3":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Viroporin activity of murine hepatitis virus E protein"},{"title3":"SARS coronavirus E protein forms cation-selective ion channels"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS"},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication"},{"title3":"Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells"},{"title3":"Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein"},{"title3":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles"},{"title3":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3"},{"title3":"A contemporary view of coronavirus transcription"},{"title3":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer"},{"title3":"Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold"},{"title3":"Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs"},{"title3":"Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch"},{"title3":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7"},{"title3":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3"},{"title3":"Novel beta -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus"},{"title3":"Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus"},{"title3":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family"},{"title3":"Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme"},{"title3":"Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication"},{"title3":"The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world"},{"title3":"Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106)."},{"title3":"Major genetic marker of nidoviruses encodes a replicative endoribonuclease"},{"title3":"Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex"},{"title3":"Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles"},{"title3":"Membrane topology of murine coronavirus replicase nonstructural protein 3"},{"title3":"Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning"},{"title3":"Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS. J"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein"},{"title3":"Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease"},{"title3":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences"},{"title3":"Analysis of the genome sequence of an alpaca coronavirus"},{"title3":"Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein"},{"title3":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features"},{"title3":"Detection of group 1 coronaviruses in bats in North America"},{"title3":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus"},{"title3":"Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China"},{"title3":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus"},{"title3":"Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA"},{"title3":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3"},{"title3":"Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein"},{"title3":"SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists"},{"title3":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism"},{"title3":"Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Differential regulation of innate and adaptive immune responses in viral encephalitis"},{"title3":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells"},{"title3":"Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon"},{"title3":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia"},{"title3":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"The immunobiology of SARS"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Lethal infection in K18-hACE2 mice infected with SARS-CoV"},{"title3":"SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Establishment of &quot;The Gene Mine&quot;: a resource for rapid identification of complex trait genes"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes"}]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"SARS coronavirus and innate immunity"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viruses and interferon: a fight for supremacy"},{"title3":"MDA5/RIG-I and virus recognition"},{"title3":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses"},{"title3":"NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections"},{"title3":"A weak signal for strong responses: interferon-alpha/beta revisited"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Innate immune response to viral infection of the lungs"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"SARS Immunity and Vaccination"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus"},{"title3":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis"},{"title3":"Th17 cell based vaccines in mucosal immunity"},{"title3":"IL-10 family of cytokines"},{"title3":"Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, . (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;id=23918362&amp;retmode=ref&amp;cmd=prlinks."},{"title3":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages"},{"title3":"Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002."}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Anonymous. MERS-COV - Eastern Mediterranean (65) Saudi Arabia, RFI, Qatar. ProMED 20130904.1919328 (2013)."},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"de Wit, E. et al. Novel human betacoronavirus causes a transient lower respiratory tract infection in a rhesus macaque model. Proc. Natl. Acad. Sci. USA (in the press)."},{"title3":"Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013. MMWR Morb. Mortal. Wkly. Rep.62, 480-483 (2013)."},{"title3":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models"},{"title3":"Interferon signaling and treatment outcome in chronic hepatitis C"},{"title3":"Branch mode selection during early lung development"},{"title3":"Expression of SHH signaling pathway components in the developing human lung"},{"title3":"Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways"},{"title3":"Hedgehog signaling in neonatal and adult lung"},{"title3":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network"},{"title3":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains"},{"title3":"The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis"},{"title3":"Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease"},{"title3":"Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia"},{"title3":"Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway"},{"title3":"Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung"},{"title3":"Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill.18, 20427 (2013)."},{"title3":"Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus"},{"title3":"Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls"},{"title3":"Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial","References":[{"title3":"World Health Organization: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 14 Jan 2018."},{"title3":"Middle East Respiratory Syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A review of treatment modalities for Middle East Respiratory Syndrome"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis"},{"title3":"Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study"},{"title3":"Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS)"},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Abbott Laboratories. Product Information: Kaletra . https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021226s030lbl.pdf. Accessed 14 Jan 2018."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"SPIRIT 2013 statement: defining standard protocol items for clinical trials"},{"title3":"Chang, M. Adaptive Design Theory and implementation using SAS and R, 2nd ed. Chapman and Hall/CRC. 2014. Pp. 153-180."},{"title3":"Acute renal failure:definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, 39, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39)."},{"title3":"Classification of acute pancreatitis:2012: revision of the Atlanta classification and definitions by international consensus"},{"title3":"Evaluating cancer patients for rehabilitation potential"},{"title3":"U.S. National Library of Medicine. LiverTox. https://livertox.nlm.nih.gov//Lopinavir.htm. Accessed 14 Jan 2018."},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Uniform requirements for manuscripts submitted to biomedical journals"},{"title3":"PubMed-cited research articles on the Middle East respiratory syndrome"},{"title3":"Non-randomised Ebola trials:lessons for optimal outbreak research"},{"title3":"Conducting research in disease outbreaks"},{"title3":"Modification of the sample-size and the schedule of interim analyses in survival trials based on data inspections"}]},{"title2":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","References":[{"title3":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"MERS-CoV Antibodies in Humans, Africa, 2013-2014"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"New Metrics for Evaluating Viral Respiratory Pathogenesis"},{"title3":"A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients"},{"title3":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance"},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China"},{"title3":"Viral Load Kinetics of MERS Coronavirus Infection"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication"},{"title3":"Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin"},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"}]},{"title2":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","References":[{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"Dudas, G., Carvalho, L. M., Rambaut, A. &amp; Bedford, T. MERS-CoV spillover at the camel-human interface. eLife7, e31257 (2018)."},{"title3":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis"},{"title3":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/ (2018)."},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Kaletra. Highlights of Prescribing Information. https://www.rxabbvie.com/pdf/kaletratabpi.pdf (2017)."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Arabi, Y. M. Twitter account for MIRACLE Trial. (2019)."},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase"},{"title3":"Tchesnokov, E. P., Feng, J. Y., Porter, D. P. &amp; Gotte, M. Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses11, 326 (2019)."},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors"},{"title3":"Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease"},{"title3":"Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain"},{"title3":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals"},{"title3":"Arabi, Y. M. MERS-CoV infection treated with a combination of lopinavir/ritonavir and interferon beta-1b (MIRACLE). https://clinicaltrials.gov/ct2/show/NCT02845843 (2016)."},{"title3":"New metrics for evaluating viral respiratory pathogenesis"},{"title3":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection"},{"title3":"Lossi, L., Castagna, C. &amp; Merighi, A. Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. Int. J. Mol. Sci.19, 3999 (2018)."},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Coronaviruses:drug discovery and therapeutic options"},{"title3":"Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy"},{"title3":"Clinical uses of interferons"},{"title3":"Virus interference. I. The interferon"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness"},{"title3":"The Superiority of IFN-lambda as a therapeutic candidate to control acute influenza viral lung infection"},{"title3":"Mouse models of acute respiratory distress syndrome: a review of analytical approaches, pathologic features, and common measurements"},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. Investigational Therapeutics for the Treatment of People With Ebola Virus Disease NCT03719586. https://clinicaltrials.gov/ct2/show/NCT03719586?term=NCT03719586&amp;draw=2&amp;rank=1 (2019)."},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen NCT02818582. https://clinicaltrials.gov/ct2/show/NCT02818582?term=NCT02818582&amp;draw=2&amp;rank=1 (2019)."},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets"},{"title3":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio9, e00221-18(2018)."},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Betaseron. Highlights of Prescribing Information. https://labeling.bayerhealthcare.com/html/products/pi/Betaseron_PI.pdf (2015)."},{"title3":"A simple practice guide for dose conversion between animals and human"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method"}]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses in bats from Mexico"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Host range, prevalence, and genetic diversity of adenoviruses in bats"},{"title3":"Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray"},{"title3":"Evolutionary relationships between bat coronaviruses and their hosts"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"RDP3: a flexible and fast computer program for analyzing recombination"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Prediction and prevention of the next pandemic zoonosis"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry"}]},{"title2":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting","References":[{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"First isolation and characterization of bat SARS-like coronaviruses that use the ACE2 receptor"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"SARS-CoV infection in a restaurant from palm civet"}]}]},{"title1":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[{"title2":"Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis","References":[{"title3":"Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis"},{"title3":"2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary"},{"title3":"Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis"},{"title3":"Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis"},{"title3":"Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation"},{"title3":"Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease"},{"title3":"Efficacy and cardiovascular tolerability of continuous veno-venous hemodiafiltration in acute decompensated heart failure: a randomized comparative study"},{"title3":"Rapid resolution of acute fulminant myocarditis after IVIG and steroid treatment"},{"title3":"Fulminant myocarditis in children successfully treated with high dose of methyl-prednisolone"},{"title3":"Human parvovirus B19-associated myocarditis"},{"title3":"Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy"},{"title3":"Use of the Impella 5.0 device as a bridge to recovery in adult fulminant viral myocarditis"},{"title3":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases"},{"title3":"Myocarditis: a clinical overview"},{"title3":"Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care"},{"title3":"Corticosteroids for viral myocarditis"},{"title3":"Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1"},{"title3":"Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients"},{"title3":"Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-C ourse, and Survival (ETiCS) Study"},{"title3":"Extracorporeal membrane oxygenation for the support of adults with acute myocarditis"},{"title3":"Gamma-globulin treatment of acute myocarditis in the pediatric population"},{"title3":"Immunoadsorption therapy in dilated cardiomyopathy"},{"title3":"Echocardiographic findings in fulminant and acute myocarditis"},{"title3":"Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study"},{"title3":"Myocarditis"},{"title3":"Immune checkpoint inhibitorassociated myocarditis"},{"title3":"Fulminant myocarditis"},{"title3":"Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature"},{"title3":"Guidelines for diagnosis and treatment of myocarditis (JCS 2009)"},{"title3":"Fulminant myocarditis"},{"title3":"Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience"},{"title3":"Analysis of ECMO treatment in five fulminant myocarditis patients"},{"title3":"The European study of epidemiology and treatment of cardiac inflammatory disease (ESETCID)"},{"title3":"Intra-aortic balloon pump"},{"title3":"Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses"},{"title3":"Emerging pharmacologic targets and treatments for myocarditis"},{"title3":"Efficacy of circulatory support in patients with cardiogenic shock"},{"title3":"Fulminant myocarditis with combination immune checkpoint blockade"},{"title3":"Update on myocarditis"},{"title3":"Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance"},{"title3":"Interferon-Beta improves survival in enterovirus-associated cardiomyopathy"},{"title3":"Established and novel treatment options in acute myocarditis, with or without heart failure"},{"title3":"2011 consensus statement on endomyocardial biopsy from the association for European cardiovascular pathology and the society for cardiovascular pathology"},{"title3":"A life support based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis:a multiple center study"},{"title3":"Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience"},{"title3":"What's new in myocarditis"},{"title3":"Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock"},{"title3":"Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device"},{"title3":"Virus serology in patients with suspected myocarditis: utility or futility"},{"title3":"Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options"},{"title3":"Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea"},{"title3":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure"},{"title3":"Noninvasive ventilation in acute cardiogenic pulmonary edema: a meta-analysis of randomized controlled trials"},{"title3":"Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012"},{"title3":"Statistical analysis on differences in different treatments for adults with fulminant myocarditis"},{"title3":"N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVECHF study"},{"title3":"Use of B-type natriuretic peptide for the management of women with dyspnea"},{"title3":"Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: a retrospective single-center study"},{"title3":"Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support"},{"title3":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure"},{"title3":"Transbrachial intra-aortic balloon pumping for a patient with fulminant myocarditis"},{"title3":"2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary"},{"title3":"Percutaneous mechanical circulatory support using Impella devices for decompensated cardiogenic shock"},{"title3":"Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema"},{"title3":"Pathophysiology of Takotsubo syndrome"},{"title3":"Echocardiographic findings in myocarditis"},{"title3":"Viral myocarditis-diagnosis, treatment options and current controversies"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure"},{"title3":"Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients"},{"title3":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death"},{"title3":"Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Espanola de Medicina Intensiva, Critica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente Critico (GEIPC) de la Sociedad Espanola de Enfermedades Infecciosas y Microbiologia clinica (SEIMC) para el diagnostico y tratamiento de la gripe A/H1N1 en pacientes adultos graves hospitalizados en las Unidades de Cuidados Intensivos"},{"title3":"Fulminant myocarditis: the role of cardiac magnetic resonance imaging"},{"title3":"Magnetic resonance imaging for characterizing myocardial diseases"},{"title3":"Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score"},{"title3":"Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells"},{"title3":"Mechanical circulatory support in acute decompensated heart failure and shock"},{"title3":"Value of SOFA, APACHE IV and SAPS II scoring systems in predicting short-term mortality in patients with acute myocarditis"},{"title3":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABPSHOCK II): final 12 month results of a randomised, open-label trial"},{"title3":"Clinical analysis of 36 children with fulminant myocarditis"},{"title3":"Prognostic electrocardiographic parameters in patients with suspected myocarditis"},{"title3":"A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan"},{"title3":"A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan"},{"title3":"Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock"},{"title3":"Contemporary management of cardiogenic shock: a scientific statement from the American heart association"},{"title3":"Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance"},{"title3":"Contemporary management of fulminant myocarditis"},{"title3":"Sixty-four cases of fulminant myocarditis in children"},{"title3":"Application of emergency coronary angiography in adult patients with fulminant myocarditis"},{"title3":"Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema"},{"title3":"Extracorporeal membrane oxygenation for rescuing fulminant myocarditis patients complicated with multiple organ failure"},{"title3":"Repetitive fulminant influenza myocarditis requiring the use of circulatory assist devices"},{"title3":"Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: a retrospective study"},{"title3":"Mechanical support for cardiogenic shock"},{"title3":"Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases"},{"title3":"Clinical characteristics of old patients with fulminant myocarditis"}]}]},{"title1":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Critically ill patients with 2009 influenza A(H1N1) in Mexico","References":[]},{"title2":"Critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"A comprehensive review of the use and understanding of airway pressure release ventilation"},{"title3":"Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome"},{"title3":"The use of bronchoscopy in critically ill patients: considerations and complications"},{"title3":"Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome"},{"title3":"Safety of research bronchoscopy in critically ill patients"},{"title3":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients"},{"title3":"Bronchoscopy in the Intensive Care Unit"},{"title3":"The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model"},{"title3":"Changes in pulmonary mechanics after fiberoptic bronchoalveolar lavage in mechanically ventilated patients"},{"title3":"Effects on respiratory mechanics of bronchoalveolar lavage in mechanically ventilated patients"}]},{"title2":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada","References":[{"title3":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model"},{"title3":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses"},{"title3":"Immunogenicity and protective efficacy of influenza vaccination"},{"title3":"Determinants of immunity to influenza infection in man"},{"title3":"Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection"},{"title3":"Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Serological diagnosis of influenza by haemagglutination inhibition testing"},{"title3":"Host adaptive immunity deficiency in severe pandemic influenza"},{"title3":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study"},{"title3":"Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations"},{"title3":"Serum and mucosal antibodies fail as prognostic markers during critical influenza A infection"},{"title3":"Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome"},{"title3":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness"},{"title3":"Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores"},{"title3":"Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection"},{"title3":"Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia"},{"title3":"Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes"},{"title3":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain"},{"title3":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States"},{"title3":"Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis"}]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city","References":[]},{"title2":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"A comprehensive review of the use and understanding of airway pressure release ventilation"},{"title3":"Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome"},{"title3":"The use of bronchoscopy in critically ill patients: considerations and complications"},{"title3":"Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome"},{"title3":"Safety of research bronchoscopy in critically ill patients"},{"title3":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients"},{"title3":"Bronchoscopy in the Intensive Care Unit"},{"title3":"The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model"},{"title3":"Changes in pulmonary mechanics after fiberoptic bronchoalveolar lavage in mechanically ventilated patients"},{"title3":"Effects on respiratory mechanics of bronchoalveolar lavage in mechanically ventilated patients"}]},{"title2":"Short-term outcome of critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Centers for Disease Control and Prevention (2003) Updated interim US case definition for severe acute respiratory syndrome (SARS)-update, 30 April 2003 http://www.cdc.gov/ncidod/sars/casedefinition.htm"},{"title3":"Leigh JM (1990) Oxygen therapy. In: Scurr C, Feldman S, Soni N (eds) Scientific foundations of anaesthesia, 4th edn. Heinemann Medical Books, Oxford, pp 287-296"}]},{"title2":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","References":[]},{"title2":"SARS and MERS: recent insights into emerging coronaviruses","References":[{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"WHO. Summary of probably SARS cases with onset of illness from 1 November 2002 to 31 July 2003. WHO, http://www.who.int/csr/sars/country/table2004_04_21/en/ (2004)."},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Patient with new strain of coronavirus is treated in intensive care at London hospital"},{"title3":"Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res. Perspect.6, 269-278 (2015)."},{"title3":"WHO. Coronavirus infections: disease outbreak news. WHO, http://www.who.int/csr/don/26-april-2016-mers-saudi-arabia/en/ (2016)."},{"title3":"Nidovirus transcription: how to make sense...?"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Review of bats and SARS"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"MERS coronavirus in dromedary camel herd, Saudi Arabia"},{"title3":"Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014"},{"title3":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Biomarkers in acute respiratory distress syndrome"},{"title3":"The mercurial nature of neutrophils: still an enigma in ARDS?"},{"title3":"SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the Collaborative Cross"},{"title3":"Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-O-methyltransferase activity"},{"title3":"Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments"},{"title3":"The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity"},{"title3":"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression"},{"title3":"SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage"},{"title3":"A two-pronged strategy to suppress host protein synthesis by SARS coronavirus nsp1 protein"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin"},{"title3":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"MAVS-mediated apoptosis and its inhibition by viral proteins"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Mechanisms of action of ribavirin against distinct viruses"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Clinical analysis of the first patient with imported Middle East respiratory syndrome in China"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"Kim, U. J., Won, E. J., Kee, S. J., Jung, S. I. &amp; Jang, H. C. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report. Antivir. Ther.10.3851/IMP3002 (2015)."},{"title3":"Rhee, J. Y., Hong, G. &amp; Ryu, K. M. Clinical implications of five cases of Middle East respiratory syndrome coronavirus infection in South Korea Outbreak. Jpn J. Infect. Dis.10.7883/yoken.JJID.2015.445 (2016)."},{"title3":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design"},{"title3":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus"},{"title3":"Ligand-induced dimerization of Middle East respiratory syndrome (MERS) coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"International Severe Acute Respiratory &amp; Emerging Infection Consortium. Treatment of MERS-CoV: decision support tool. International Severe Acute Respiratory &amp; Emerging Infection Consortium, https://isaric.tghn.org/site_media/media/articles/Decision_Support_Document_v1_1_20130729.pdf (updated 29 July 2013)."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"},{"title3":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"The role of C5a in acute lung injury induced by highly pathogenic viral infections"},{"title3":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus"},{"title3":"A decade after SARS: strategies for controlling emerging coronaviruses"},{"title3":"SARS vaccines: where are we?"},{"title3":"Middle East respiratory syndrome: current status and future prospects for vaccine development"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge"},{"title3":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates"},{"title3":"Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"SARS-like WIV1-CoV poised for human emergence"}]},{"title2":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","References":[]},{"title2":"China built a hospital in 10 days to battle coronavirus","References":[]},{"title2":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"China coronavirus: six questions scientists are asking."}]},{"title2":"Asymptomatic cases complicate efforts","References":[]},{"title2":"Multiple organ infection and the pathogenesis of SARS","References":[{"title3":"World Health Organization. Communicable Disease Surveillance &amp; Response (CSR). Severe Acute Respiratory Syndrome (SARS). Available at: http://www.who.int/csr/sars/en (accessed July 11, 2005)."},{"title3":"World Health Organization. May 1, 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/."},{"title3":"Lossi L., P. Aimar, E. Beltramo, and A. Merighi. 2002. Immunogold labeling techniques for transmission electron microscopy: applications in cell and molecular biology. Gold and Silver Staining: Techniques in Molecular Morphology. G.W. Hacker and J. Gu, editors. CRC Press, Boca Raton, FL. 147-167"},{"title3":"Shi, S.R., J. Gu, J.F. Turrens, R.J. Cote, and C.R. Taylor. 2000. Development of AR technique: philosophy and theoretical base. Antigen Retrieval. S.R. Shi, J. Gu, C.R. Taylor, editors., Eaton Publishing Co. Natick, MA. 17-39."}]},{"title2":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","References":[]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses"},{"title3":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Antibody response and disease severity in healthcare worker MERS survivors"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex"},{"title3":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"The HLA-A2-supermotif: a QSAR definition"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC"},{"title3":"Vaccines for the prevention against the threat of MERS-CoV"},{"title3":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity"},{"title3":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells"},{"title3":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"Improved transgenic mouse model for studying HLA class I antigen presentation"},{"title3":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling"},{"title3":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes"},{"title3":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein"},{"title3":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development"},{"title3":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC"},{"title3":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV"},{"title3":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity"},{"title3":"Serological assays for emerging coronaviruses: challenges and pitfalls"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"The structure and function of CD26 in the T-cell immune response"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Specific serology for emerging human coronaviruses by protein microarray"},{"title3":"Geographic distribution of MERS coronavirus among dromedary camels, Africa"},{"title3":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity"},{"title3":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A comprehensive comparison of transmembrane domains reveals organelle-specific properties"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes"},{"title3":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"From SARS coronavirus to novel animal and human coronaviruses"},{"title3":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Middle East respiratory syndrome and severe acute respiratory syndrome"},{"title3":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses"},{"title3":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848"},{"title3":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes"},{"title3":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"}]},{"title2":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study","References":[]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]}]}]}